APA (7th ed.) Citation

Hirota, K., Kawaguchi, T., Koya, S., Nagamatsu, A., Tomita, M., Hashida, R., . . . Torimura, T. (2020). Clinical utility of the Liver Frailty Index for predicting muscle atrophy in chronic liver disease patients with hepatocellular carcinoma. Hepatology Research, 50(3), 330. https://doi.org/10.1111/hepr.13453

Chicago Style (17th ed.) Citation

Hirota, Keisuke, et al. "Clinical Utility of the Liver Frailty Index for Predicting Muscle Atrophy in Chronic Liver Disease Patients with Hepatocellular Carcinoma." Hepatology Research 50, no. 3 (2020): 330. https://doi.org/10.1111/hepr.13453.

MLA (9th ed.) Citation

Hirota, Keisuke, et al. "Clinical Utility of the Liver Frailty Index for Predicting Muscle Atrophy in Chronic Liver Disease Patients with Hepatocellular Carcinoma." Hepatology Research, vol. 50, no. 3, 2020, p. 330, https://doi.org/10.1111/hepr.13453.